Leukemia research

Keyphrases

Publications

volume 146, 2024

Rohan K Achar, Benjamin J McCormick, Emily Dworkin, Emily M Geramita, Annie Im, Anand A Patel, Talha Badar, Rory M Shallis
Outcomes of patients with acute myeloid leukemia treated with intensive therapy after failure of venetoclax-inclusive, less-intensive therapy. Leukemia research 146 (2024)
Rahul Mishra, Cassandra Calabrese, Akriti G Jain, Abhay Singh
Association between myeloid disorders and adult onset-inflammatory syndromes, successful treatment with JAK-inhibitors: Case series and literature review. Leukemia research 146 (2024)
Ming Lei, Juan Liang, Kaiyun Guo, Langui Tang, Yuxing He, Xuefeng Wu
Roles of noncoding RNAs in multiple myeloma. Leukemia research 146 (2024)
Zhencang Zhou, Pinwei Zhu, Jinli Ge, Qiang Li, Hang Li, Nana Zhe, Zhaoyu Liu, Dengke Chen
Gene regulatory mechanisms of T cell exhaustion in diffuse large B cell lymphoma based on single-cell transcriptome data. Leukemia research 146 (2024)
Ambarina S Faiz, Shuang Guo, Ashwin Sridharan, Yong Lin, Claire S Philipp
Risk factors and mortality associated with venous thromboembolism in the elderly US population with chronic lymphocytic leukemia. Leukemia research 146 (2024)

volume 145, 2024

Serena Travaglini, Giorgia Silvestrini, Enrico Attardi, Maurizio Fanciulli, Stefano Scalera, Silvia Antonelli, Luca Maurillo, Raffaele Palmieri, Mariadomenica Divona, Ludovica Ciuffreda, Arianna Savi, Giovangiacinto Paterno, Tiziana Ottone, Caterina Barbieri, Jaroslaw P Maciejewski, Carmelo Gurnari, Gennaro Ciliberto, Maria Teresa Voso
Evolution of transcriptomic profiles in relapsed inv(16) acute myeloid leukemia. Leukemia research 145 (2024)
Yael Kusne, Talha Badar, Terra Lasho, Alejandro Ferrer, Abhishek A Mangaonkar, Christy Finke, Ludovica Marando, James M Foran, Aref Al-Kali, Hassan B Alkhateeb, Timothy Chlon, Mrinal M Patnaik
Absence of PNH-clones in DDX41mutant-GPS aids in their distinction from acquired BM failure syndromes. Leukemia research 145 (2024)
Qiang Fu, Yunqi Wang, Hongtao Liu, Haitao Gao, Wei Sun, Qian Jiang, Hao Jiang, Kaiyan Liu, Xiaojun Huang, Feifei Tang
Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 mut acute myeloid leukemia. Leukemia research 145 (2024)
Amrita Desai, Yazeed Samara, Dongyun Yang, Brian Ball, Adam Braun, Paul Koller, Amanda Blackmon, Vaibhav Agrawal, Hoda Pourhassan, Idoroenyi Amanam, Shukaib Arslan, Salman Otoukesh, Karamjeet Sandhu, Ibrahim Aldoss, Haris Ali, Amandeep Salhotra, Monzr M Al Malki, Andrew Artz, Pamela Becker, Eileen Smith, Anthony Stein, Guido Marcucci, Stephen J Forman, Peter Curtin, Ryotaro Nakamura, Vinod Pullarkat
Impact of spliceosome mutation on outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia patients undergoing allogeneic hematopoietic cell transplantation. Leukemia research 145 (2024)
Silvia Cingelova, Eva Mikuskova, Ludmila Demitrovicova, Vanda Mikudova, Alica Slobodova, Jana Spanikova, Radka Vasickova, Denis Urban, Lubos Drgona, Iveta Oravcova
Distinctive features associated with differentiation syndrome in acute promyelocytic leukemia in patients treated by all-trans retinoic acid and arsenic trioxide. Leukemia research 145 (2024)
Tingting Li, Qingya Cui, Sining Liu, Zheng Li, Wei Cui, Mengyun Li, Yunju Ma, Xuanqi Cao, Xiaming Zhu, Liqing Kang, Lei Yu, Depei Wu, Xiaowen Tang
Decitabine consolidation after CD19/CD22 CAR-T therapy as a novel maintenance treatment significantly improves survival outcomes in relapsed/refractory B-ALL patients. Leukemia research 145 (2024)
Juan Pablo Diaz Martinez, Therese Aubry de Maraumont, Luis Miguel Camacho, Laura Garcia
Cost-effectiveness of blinatumomab for the treatment of B‑precursor acute lymphoblastic leukemia pediatric patients with high‑risk first‑relapse in Mexico. Leukemia research 145 (2024)

volume 144, 2024

Shuangshuang Wu, Fangbing Liu, Yuqing Gai, Jenna Carter, Holly Edwards, Maik Hüttemann, Guan Wang, Chunhuai Li, Jeffrey W Taub, Yue Wang, Yubin Ge
Combining the novel FLT3 and MERTK dual inhibitor MRX-2843 with venetoclax results in promising antileukemic activity against FLT3-ITD AML. Leukemia research 144 (2024)
Kanak Parmar, Rupayan Kundu, Abhishek Maiti, Somedeb Ball
Updates in biology, classification, and management of acute myeloid leukemia with antecedent hematologic disorder and therapy related acute myeloid leukemia. Leukemia research 144 (2024)
David McCall, Tareq Abuasab, Juan Jose Rodriguez-Sevilla, Shehab Fareed Mohamed, Anish Patnaik, Kirthi Devireddy, Naszrin Arani, Irtiza Sheikh, Raehannah Jamshidi, Amber Gibson, Michael Roth, Cesar Nuñez, Miriam Garcia, Kelly S Chien, Sanam Loghavi, Sherry A Pierce, Koji Sasaki, Ghayas Issa, Branko Cuglievan, Hagop Kantarjian, Guillermo Garcia-Manero
Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysis. Leukemia research 144 (2024)
Shuangshuang Wu, Fangbing Liu, Yuqing Gai, Jenna Carter, Holly Edwards, Maik Hüttemann, Guan Wang, Chunhuai Li, Jeffrey W Taub, Yue Wang, Yubin Ge
Combining the novel FLT3 and MERTK dual inhibitor MRX-2843 with venetoclax results in promising antileukemic activity against FLT3-ITD AML. Leukemia research 144 (2024)
Matteo Molica, Salvatore Perrone, Marco Rossi, Diana Giannarelli
The impact of different FLT3-inhibitors on overall survival of de novo acute myeloid leukemia: A network meta-analysis. Leukemia research 144 (2024)
Chunfang Kong, Mei Wu, Qilin Lu, Bo Ke, Jianhui Xie, Anna Li
PI3K/AKT confers intrinsic and acquired resistance to pirtobrutinib in chronic lymphocytic leukemia. Leukemia research 144 (2024)
Chunfang Kong, Mei Wu, Qilin Lu, Bo Ke, Jianhui Xie, Anna Li
PI3K/AKT confers intrinsic and acquired resistance to pirtobrutinib in chronic lymphocytic leukemia. Leukemia research 144 (2024)
Hiroaki Shimizu, Jun Kato, Susumu Tanoue, Shun-Ichi Kimura, Takayoshi Tachibana, Kaoru Hatano, Kensuke Usuki, Jun Taguchi, Maki Hagihara, Nobuhiro Tsukada, Kaito Harada, Satoshi Takahashi, Satoru Takada, Emiko Sakaida, Shin Fujisawa, Masahiro Onoda, Nobuyuki Aotsuka, Hiroshi Handa, Yoshihiro Hatta, Reiko Nakaseko, Shingo Yano, Kazuteru Ohashi, Yoshinobu Kanda, null null
Allogeneic stem cell transplant with TBI-based myeloablative conditioning in adolescents and young adults with Philadelphia chromosome-negative ALL treated with pediatric protocols. Leukemia research 144 (2024)
Heran Cui, Yuanyang Ma, Shulin Han, Xiaodong Zhang, Weiya Fu, Shuang Yang, Tianhang Liu, Xuefang Zhang
Arsenic trioxide regulates the glycolytic pathway to treat acute promyelocytic leukemia by inhibiting RPL22L1. Leukemia research 144 (2024)
David McCall, Tareq Abuasab, Juan Jose Rodriguez-Sevilla, Shehab Fareed Mohamed, Anish Patnaik, Kirthi Devireddy, Naszrin Arani, Irtiza Sheikh, Raehannah Jamshidi, Amber Gibson, Michael Roth, Cesar Nuñez, Miriam Garcia, Kelly S Chien, Sanam Loghavi, Sherry A Pierce, Koji Sasaki, Ghayas Issa, Branko Cuglievan, Hagop Kantarjian, Guillermo Garcia-Manero
Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysis. Leukemia research 144 (2024)
Matteo Molica, Salvatore Perrone, Marco Rossi, Diana Giannarelli
The impact of different FLT3-inhibitors on overall survival of de novo acute myeloid leukemia: A network meta-analysis. Leukemia research 144 (2024)
Hiroaki Shimizu, Jun Kato, Susumu Tanoue, Shun-Ichi Kimura, Takayoshi Tachibana, Kaoru Hatano, Kensuke Usuki, Jun Taguchi, Maki Hagihara, Nobuhiro Tsukada, Kaito Harada, Satoshi Takahashi, Satoru Takada, Emiko Sakaida, Shin Fujisawa, Masahiro Onoda, Nobuyuki Aotsuka, Hiroshi Handa, Yoshihiro Hatta, Reiko Nakaseko, Shingo Yano, Kazuteru Ohashi, Yoshinobu Kanda, null null
Allogeneic stem cell transplant with TBI-based myeloablative conditioning in adolescents and young adults with Philadelphia chromosome-negative ALL treated with pediatric protocols. Leukemia research 144 (2024)
Heran Cui, Yuanyang Ma, Shulin Han, Xiaodong Zhang, Weiya Fu, Shuang Yang, Tianhang Liu, Xuefang Zhang
Arsenic trioxide regulates the glycolytic pathway to treat acute promyelocytic leukemia by inhibiting RPL22L1. Leukemia research 144 (2024)
Kanak Parmar, Rupayan Kundu, Abhishek Maiti, Somedeb Ball
Updates in biology, classification, and management of acute myeloid leukemia with antecedent hematologic disorder and therapy related acute myeloid leukemia. Leukemia research 144 (2024)

volume 143, 2024

Emma Zulch, Yoshitaka Inoue, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej, Myles Nickolich, Hong Zheng, Seema Naik, Witold Rybka, Christopher Ehmann, Jeffrey Sivik, Jseph Mierski, Brooke Silar, Caitlin Vajdic, Robert Greiner, Valerie Brown, Raymond Hohl, David Claxton, Hiroko Shike, Catharine I Paules, Shin Mineishi, Kentaro Minagawa
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia research 143 (2024)
Stephanie Boisclair, Edward Zhou, Phyu Naing, Richa Thakur, Erin Jou, Bradley Goldberg, Douglas E Gladstone, Steven L Allen, Jonathan E Kolitz, David W Chitty
Less is more: An analysis of venetoclax and hypomethylating agent post-induction treatment modifications in AML. Leukemia research 143 (2024)
Mobil Akhmedov, Pervin Zeynalova, Alexander Fedenko
Multiple myeloma and infections in the era of novel treatment modalities. Leukemia research 143 (2024)
Hendrik Jestrabek, Viktoria Kohlhas, Michael Hallek, Phuong-Hien Nguyen
Impact of leukemia-associated macrophages on the progression and therapy response of chronic lymphocytic leukemia. Leukemia research 143 (2024)
Zhifang Xu, Ting Zhang, Jian Hao, Dan Liu, Minglin Hong, Shaotong Dong, Ju Deng, Fanggang Ren, Yaofang Zhang, Hongwei Wang
Identification of clonal relationship and prognostic significance in acute myeloid leukemia patients with concomitant increase in mast cells. Leukemia research 143 (2024)
Mobil Akhmedov, Pervin Zeynalova, Alexander Fedenko
Multiple myeloma and infections in the era of novel treatment modalities. Leukemia research 143 (2024)
Stephanie Boisclair, Edward Zhou, Phyu Naing, Richa Thakur, Erin Jou, Bradley Goldberg, Douglas E Gladstone, Steven L Allen, Jonathan E Kolitz, David W Chitty
Less is more: An analysis of venetoclax and hypomethylating agent post-induction treatment modifications in AML. Leukemia research 143 (2024)
Dong-Yeop Shin, Sahee Park, Eunjung Jang, Jee Hyun Kong, Young-Woong Won, Sukjoong Oh, Yunsuk Choi, Jeong-A Kim, Se Won Lee, Yeung-Chul Mun, Hawk Kim, Sung-Hyun Kim, Young Rok Do, Jae-Yong Kwak, Hyeoung-Joon Kim, Dae Young Zang, Sung-Nam Lim, Won Sik Lee, Dong-Wook Kim
Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials. Leukemia research 143 (2024)
Piero Galieni, Emanuela Troiani, Paola Picardi, Mario Angelini, Francesca Mestichelli, Alessia Dalsass, Denise Maravalle, Elisa Camaioni, Catia Bigazzi, Patrizia Caraffa, Miriana Ruggieri, Serena Mazzotta, Silvia Mattioli, Stefano Angelini
Unmutated IGHV at diagnosis in patients with early stage CLL independently predicts for shorter follow-up time to first treatment (TTFT). Leukemia research 143 (2024)
Kurtis Edwards, Maria Manoussaka, Uzma Sayed, Tamar Tsertsvadze, Lara De Deyn, Amit Nathwani, John G Gribben, Sergey Krysov, Emanuela V Volpi, Peter M Lydyard, Nino Porakishvili
MD-1 downregulation is associated with reduced cell surface CD180 expression in CLL. Leukemia research 143 (2024)
Alessandro Busca
Post-transplant cyclophosphamide: A double-edged sword? Leukemia research 143 (2024)
Dong-Yeop Shin, Sahee Park, Eunjung Jang, Jee Hyun Kong, Young-Woong Won, Sukjoong Oh, Yunsuk Choi, Jeong-A Kim, Se Won Lee, Yeung-Chul Mun, Hawk Kim, Sung-Hyun Kim, Young Rok Do, Jae-Yong Kwak, Hyeoung-Joon Kim, Dae Young Zang, Sung-Nam Lim, Won Sik Lee, Dong-Wook Kim
Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials. Leukemia research 143 (2024)
Zhifang Xu, Ting Zhang, Jian Hao, Dan Liu, Minglin Hong, Shaotong Dong, Ju Deng, Fanggang Ren, Yaofang Zhang, Hongwei Wang
Identification of clonal relationship and prognostic significance in acute myeloid leukemia patients with concomitant increase in mast cells. Leukemia research 143 (2024)
Kurtis Edwards, Maria Manoussaka, Uzma Sayed, Tamar Tsertsvadze, Lara De Deyn, Amit Nathwani, John G Gribben, Sergey Krysov, Emanuela V Volpi, Peter M Lydyard, Nino Porakishvili
MD-1 downregulation is associated with reduced cell surface CD180 expression in CLL. Leukemia research 143 (2024)
Alessandro Busca
Post-transplant cyclophosphamide: A double-edged sword? Leukemia research 143 (2024)
Emma Zulch, Yoshitaka Inoue, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej, Myles Nickolich, Hong Zheng, Seema Naik, Witold Rybka, Christopher Ehmann, Jeffrey Sivik, Jseph Mierski, Brooke Silar, Caitlin Vajdic, Robert Greiner, Valerie Brown, Raymond Hohl, David Claxton, Hiroko Shike, Catharine I Paules, Shin Mineishi, Kentaro Minagawa
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation. Leukemia research 143 (2024)
Hendrik Jestrabek, Viktoria Kohlhas, Michael Hallek, Phuong-Hien Nguyen
Impact of leukemia-associated macrophages on the progression and therapy response of chronic lymphocytic leukemia. Leukemia research 143 (2024)
Danielle Tavares Vianna, Barbara da Costa Reis Monte-Mór, Elda Pereira Noronha, Luciana Mayumi Gutiyama, Elaine Sobral da Costa, Maria S Pombo-de-Oliveira, Ilana Zalcberg
Molecular characterization of V(D)J rearrangements in immature acute leukemias. Leukemia research 143 (2024)
Piero Galieni, Emanuela Troiani, Paola Picardi, Mario Angelini, Francesca Mestichelli, Alessia Dalsass, Denise Maravalle, Elisa Camaioni, Catia Bigazzi, Patrizia Caraffa, Miriana Ruggieri, Serena Mazzotta, Silvia Mattioli, Stefano Angelini
Unmutated IGHV at diagnosis in patients with early stage CLL independently predicts for shorter follow-up time to first treatment (TTFT). Leukemia research 143 (2024)

volume 142, 2024

Tishya Indran, Tongted Das, Jenny Muirhead, Maureen O'Brien, Michael I Swain, Bianca Cirone, Jaqueline Widjaja, Sushrut Patil, David J Curtis
Donor Lymphocyte Infusion (DLI) post allogeneic stem cell transplant (allo-SCT) in Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS). A longitudinal retrospective study using peripheral blood (PB) CD34 + and CD3 + donor chimerism (DC) monitoring. Leukemia research 142 (2024)
Guillermo Montalban-Bravo, Elias Jabbour, Kelly Chien, Danielle Hammond, Nicholas Short, Farhad Ravandi, Marina Konopleva, Gautam Borthakur, Naval Daver, Rashmi Kanagal-Shammana, Sanam Loghavi, Wei Qiao, Xuelin Huang, Heather Schneider, Meghan Meyer, Hagop Kantarjian, Guillermo Garcia-Manero
Phase 1 study of azacitidine in combination with quizartinib in patients with FLT3 or CBL mutated MDS and MDS/MPN. Leukemia research 142 (2024)
Mingshan Sun, Shijie Li, Zhenyi Liu, Sai Ma, Xiaohan Liu, Qing Meng, Yueyue Zheng, Chunyan Chen
Efficacy and safety of flumatinib in the treatment of newly diagnosed chronic myeloid leukemia in the chronic phase: A real-world single-center retrospective study, with a focus on premature drug discontinuation. Leukemia research 142 (2024)
Peter Olujimi Odutola, Peter Oluwatobi Olorunyomi, Ifeoluwapo Olorunyomi
Single vs double umbilical cord blood transplantation in acute leukemia: Systematic review and meta-analysis. Leukemia research 142 (2024)
Tishya Indran, Tongted Das, Jenny Muirhead, Maureen O'Brien, Michael I Swain, Bianca Cirone, Jacqueline Widjaja, Sushrut Patil, David J Curtis
Donor Lymphocyte Infusion (DLI) post allogeneic stem cell transplant (allo-SCT) in Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS). A longitudinal retrospective study using peripheral blood (PB) CD34 + and CD3 + donor chimerism (DC) monitoring. Leukemia research 142 (2024)